Clinical trial
A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye
NCT03368404 is registered in ClinicalTrials.gov with Laboratoire Chauvin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye
- Lead sponsor
- Laboratoire Chauvin
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 9, 2017
- Completion date
- June 2, 2020
- Enrollment
- 92 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye